2021.12.21
2021.12Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Warning: Undefined array key "jump" in /home/xs347431/standardbiotools-japan.com/public_html/wp-content/themes/fluidigm-solution/footer.php on line 48
